开云app官网登录入口网页版-官方正版

#EMR#

26篇内容 | 1795人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2164392, encodeId=5d4a216439257, content=<a href='/topic/show?id=9dbd3059eeb' target=_blank style='color:#2F92EE;'>#内镜黏膜下剥离术#</a>(ESD)是为了提高内镜黏膜切除术(EMR)切除大于2 cm病灶的能力，但与<a href='/topic/show?id=ac106e33e1' target=_blank style='color:#2F92EE;'>#EMR#</a>相比需要额外的技术技巧、延长手术时间、增加出血和穿孔等不良事件的发生率。迟发性出血是<a href='/topic/show?id=7770e00507' target=_blank style='color:#2F92EE;'>#ESD#</a>术后最常见的并发症，发生率为4.1% ~ 11.8%。虽然预防性对人工溃疡的基底血管进行<a href='/topic/show?id=aac931312ad' target=_blank style='color:#2F92EE;'>#凝血#</a>(ESD后凝血)和<a href='/topic/show?id=02f99235e23' target=_blank style='color:#2F92EE;'>#质子泵抑制剂#</a>(PPI)是胃ESD术后常规使用的方法，以最大限度地减少延迟性出血的风险，但据报道，即使使用这些方法，出血率仍为3-5.5%。, objectTitle=Digestive Endoscopy：抽吸凝血方法降低胃内镜黏膜下剥离术后迟发性出血的风险, objectType=article, longId=797316, objectId=00f3e97316fd, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/202301009/1696895568746_4754896.jpeg, objectUrl=/article/show_article.do?id=00f3e97316fd, replyNumber=0, likeNumber=83, createdTime=2023-10-23, rootId=0, userName=litao2022, userId=1ff65466529, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=00f3e97316fd, moduleTitle=Digestive Endoscopy：抽吸凝血方法降低胃内镜黏膜下剥离术后迟发性出血的风险, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=00f3e97316fd)], followStatus=false, userIsMember=true, type=1, lengthMark=1), GetTopicListResponse(id=1738723, encodeId=782d1e3872329, content=<a href='/topic/show?id=ac106e33e1' target=_blank style='color:#2F92EE;'>#EMR#</a>, objectTitle=JCEM：基于EMR的混合诊断模型改进家族性高胆固醇血症的诊断, objectType=article, longId=292142, objectId=b9152921427e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b9152921427e, replyNumber=0, likeNumber=88, createdTime=2022-02-01, rootId=0, userName=ms1292405679162969, userId=944034484276, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b9152921427e, moduleTitle=JCEM：基于EMR的混合诊断模型改进家族性高胆固醇血症的诊断, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=b9152921427e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738722, encodeId=1e0c1e3872283, content=<a href='/topic/show?id=ac106e33e1' target=_blank style='color:#2F92EE;'>#EMR#</a>, objectTitle=NEJM：罗氏旗下基因泰克的类风湿药物Actemra在COVID-19 III期临床试验中未能达到其主要终点, objectType=article, longId=208482, objectId=a52b208482ca, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a52b208482ca, replyNumber=0, likeNumber=97, createdTime=2021-10-23, rootId=0, userName=ms1292405679162969, userId=944034484276, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a52b208482ca, moduleTitle=NEJM：罗氏旗下基因泰克的类风湿药物Actemra在COVID-19 III期临床试验中未能达到其主要终点, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=a52b208482ca)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738721, encodeId=ed561e3872126, content=<a href='/topic/show?id=ac106e33e1' target=_blank style='color:#2F92EE;'>#EMR#</a>, objectTitle=Circulation：ω-3多不饱和脂肪酸通过resolvin E1-ChemR23轴减轻主动脉瓣狭窄, objectType=article, longId=199978, objectId=b20b1999e88a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b20b1999e88a, replyNumber=0, likeNumber=67, createdTime=2021-06-27, rootId=0, userName=ms1292405679162969, userId=944034484276, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b20b1999e88a, moduleTitle=Circulation：ω-3多不饱和脂肪酸通过resolvin E1-ChemR23轴减轻主动脉瓣狭窄, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=b20b1999e88a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738720, encodeId=1fc21e3872042, content=<a href='/topic/show?id=ac106e33e1' target=_blank style='color:#2F92EE;'>#EMR#</a>, objectTitle=FDA批准罗氏的Actemra COVID-19试验, objectType=article, longId=190985, objectId=ad8619098568, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ad8619098568, replyNumber=0, likeNumber=114, createdTime=2020-07-16, rootId=0, userName=ms1292405679162969, userId=944034484276, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ad8619098568, moduleTitle=FDA批准罗氏的Actemra COVID-19试验, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=ad8619098568)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738717, encodeId=7d591e3871767, content=<a href='/topic/show?id=ac106e33e1' target=_blank style='color:#2F92EE;'>#EMR#</a>, objectTitle=J hepatology：Emricasan在治疗非酒精性脂肪性肝炎（NASH）肝硬化合并门脉高压中患者中的疗效, objectType=article, longId=185405, objectId=309b18540526, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=309b18540526, replyNumber=0, likeNumber=88, createdTime=2020-11-01, rootId=0, userName=ms1292405679162969, userId=944034484276, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=309b18540526, moduleTitle=J hepatology：Emricasan在治疗非酒精性脂肪性肝炎（NASH）肝硬化合并门脉高压中患者中的疗效, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=309b18540526)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738719, encodeId=2bc51e3871961, content=<a href='/topic/show?id=ac106e33e1' target=_blank style='color:#2F92EE;'>#EMR#</a>, objectTitle=FDA批准Actemra（tocilizumab）治疗重症COVID-19肺炎的III期临床试验, objectType=article, longId=190723, objectId=c191190e23e2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c191190e23e2, replyNumber=0, likeNumber=155, createdTime=2020-03-29, rootId=0, userName=ms1292405679162969, userId=944034484276, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c191190e23e2, moduleTitle=FDA批准Actemra（tocilizumab）治疗重症COVID-19肺炎的III期临床试验, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=c191190e23e2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738718, encodeId=74bb1e38718b6, content=<a href='/topic/show?id=ac106e33e1' target=_blank style='color:#2F92EE;'>#EMR#</a>, objectTitle=中国批准将罗氏的白细胞介素-6单抗Actemra，用于控制新型冠状病毒感染患者体内的炎症风暴, objectType=article, longId=189445, objectId=ee8f189445fd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ee8f189445fd, replyNumber=0, likeNumber=77, createdTime=2021-02-18, rootId=0, userName=ms1292405679162969, userId=944034484276, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ee8f189445fd, moduleTitle=中国批准将罗氏的白细胞介素-6单抗Actemra，用于控制新型冠状病毒感染患者体内的炎症风暴, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=ee8f189445fd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738716, encodeId=b1161e38716f0, content=<a href='/topic/show?id=ac106e33e1' target=_blank style='color:#2F92EE;'>#EMR#</a>, objectTitle=Circulation：ERV1/ChemR23信号可通过调节巨噬细胞氧化低密度脂蛋白的摄取和吞噬作用来预防动脉粥样硬化, objectType=article, longId=151802, objectId=c88115180232, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c88115180232, replyNumber=0, likeNumber=105, createdTime=2018-12-30, rootId=0, userName=ms1292405679162969, userId=944034484276, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c88115180232, moduleTitle=Circulation：ERV1/ChemR23信号可通过调节巨噬细胞氧化低密度脂蛋白的摄取和吞噬作用来预防动脉粥样硬化, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=c88115180232)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738715, encodeId=0fa51e38715a2, content=<a href='/topic/show?id=ac106e33e1' target=_blank style='color:#2F92EE;'>#EMR#</a>, objectTitle=CHMP对RoActemra用于活动性幼年特发性关节炎（sJIA）持积极意见, objectType=article, longId=149816, objectId=57821498160d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=57821498160d, replyNumber=0, likeNumber=77, createdTime=2018-12-04, rootId=0, userName=ms1292405679162969, userId=944034484276, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=57821498160d, moduleTitle=CHMP对RoActemra用于活动性幼年特发性关节炎（sJIA）持积极意见, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=57821498160d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738710, encodeId=69f81e38710df, content=<a href='/topic/show?id=ac106e33e1' target=_blank style='color:#2F92EE;'>#EMR#</a>, objectTitle=2017 HKGS/HKSEMR立场声明：老年糖尿病, objectType=article, longId=116348, objectId=a5b9116348aa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a5b9116348aa, replyNumber=0, likeNumber=96, createdTime=2018-03-24, rootId=0, userName=ms1292405679162969, userId=944034484276, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a5b9116348aa, moduleTitle=2017 HKGS/HKSEMR立场声明：老年糖尿病, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=a5b9116348aa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738714, encodeId=99071e38714a9, content=<a href='/topic/show?id=ac106e33e1' target=_blank style='color:#2F92EE;'>#EMR#</a>, objectTitle=上海儿童医院通过HIMSS EMRAM （住院）七级评审专家：我愿意把孙子放在这里治疗, objectType=article, longId=142722, objectId=2720142e22de, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2720142e22de, replyNumber=0, likeNumber=68, createdTime=2018-11-20, rootId=0, userName=ms1292405679162969, userId=944034484276, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2720142e22de, moduleTitle=上海儿童医院通过HIMSS EMRAM （住院）七级评审专家：我愿意把孙子放在这里治疗, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=2720142e22de)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738713, encodeId=40bd1e387135a, content=<a href='/topic/show?id=ac106e33e1' target=_blank style='color:#2F92EE;'>#EMR#</a>, objectTitle=英国NHS同意罗氏的RoActemra（IL-6抗体）治疗巨细胞动脉炎, objectType=article, longId=135990, objectId=1af9135990b7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1af9135990b7, replyNumber=0, likeNumber=80, createdTime=2018-12-15, rootId=0, userName=ms1292405679162969, userId=944034484276, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1af9135990b7, moduleTitle=英国NHS同意罗氏的RoActemra（IL-6抗体）治疗巨细胞动脉炎, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=1af9135990b7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738711, encodeId=182e1e38711f3, content=<a href='/topic/show?id=ac106e33e1' target=_blank style='color:#2F92EE;'>#EMR#</a>, objectTitle=宁波市鄞州区第二医院通过HIMSS EMRAM（住院）七级评审, objectType=article, longId=122219, objectId=98bb1222192c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=98bb1222192c, replyNumber=0, likeNumber=108, createdTime=2017-12-24, rootId=0, userName=ms1292405679162969, userId=944034484276, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=98bb1222192c, moduleTitle=宁波市鄞州区第二医院通过HIMSS EMRAM（住院）七级评审, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=98bb1222192c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738708, encodeId=78cf1e387081e, content=<a href='/topic/show?id=ac106e33e1' target=_blank style='color:#2F92EE;'>#EMR#</a>, objectTitle=厉害了！这两家医院同日通过HIMSS EMRAM（住院）七级评审, objectType=article, longId=111224, objectId=f6a9111224f4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f6a9111224f4, replyNumber=0, likeNumber=73, createdTime=2017-10-21, rootId=0, userName=ms1292405679162969, userId=944034484276, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f6a9111224f4, moduleTitle=厉害了！这两家医院同日通过HIMSS EMRAM（住院）七级评审, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=f6a9111224f4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738712, encodeId=46141e387129a, content=<a href='/topic/show?id=ac106e33e1' target=_blank style='color:#2F92EE;'>#EMR#</a>, objectTitle=NHS拒绝使用罗氏的Roactemra治疗巨细胞动脉炎, objectType=article, longId=122606, objectId=40e51226063d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=40e51226063d, replyNumber=0, likeNumber=69, createdTime=2017-12-29, rootId=0, userName=ms1292405679162969, userId=944034484276, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=40e51226063d, moduleTitle=NHS拒绝使用罗氏的Roactemra治疗巨细胞动脉炎, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=40e51226063d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738709, encodeId=f5621e387092d, content=<a href='/topic/show?id=ac106e33e1' target=_blank style='color:#2F92EE;'>#EMR#</a>, objectTitle=盛京医院通过HIMSS EMRAM七级复评, objectType=article, longId=114717, objectId=288d114e1766, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=288d114e1766, replyNumber=0, likeNumber=71, createdTime=2018-06-10, rootId=0, userName=ms1292405679162969, userId=944034484276, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=288d114e1766, moduleTitle=盛京医院通过HIMSS EMRAM七级复评, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=288d114e1766)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738707, encodeId=f7861e3870788, content=<a href='/topic/show?id=ac106e33e1' target=_blank style='color:#2F92EE;'>#EMR#</a>, objectTitle=HIMSS EMRAM新晋医院名单更新！, objectType=article, longId=83072, objectId=39f9830e28e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=39f9830e28e, replyNumber=0, likeNumber=118, createdTime=2017-03-27, rootId=0, userName=ms1292405679162969, userId=944034484276, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=39f9830e28e, moduleTitle=HIMSS EMRAM新晋医院名单更新！, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=39f9830e28e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738703, encodeId=90161e3870300, content=<a href='/topic/show?id=ac106e33e1' target=_blank style='color:#2F92EE;'>#EMR#</a>, objectTitle=DDW 2016：内镜下黏膜切除术(EMR)后粘膜缺损切缘热消融可显著减少腺瘤复发, objectType=article, longId=70388, objectId=a438e038836, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a438e038836, replyNumber=0, likeNumber=119, createdTime=2016-10-06, rootId=0, userName=ms1292405679162969, userId=944034484276, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a438e038836, moduleTitle=DDW 2016：内镜下黏膜切除术(EMR)后粘膜缺损切缘热消融可显著减少腺瘤复发, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=a438e038836)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738704, encodeId=916b1e387041e, content=<a href='/topic/show?id=ac106e33e1' target=_blank style='color:#2F92EE;'>#EMR#</a>, objectTitle=罗氏Actemra/RoActemra治疗巨细胞动脉炎维持无激素缓解（TFR）, objectType=article, longId=70616, objectId=01b3e0616c2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=01b3e0616c2, replyNumber=0, likeNumber=71, createdTime=2016-06-24, rootId=0, userName=ms1292405679162969, userId=944034484276, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=01b3e0616c2, moduleTitle=罗氏Actemra/RoActemra治疗巨细胞动脉炎维持无激素缓解（TFR）, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=01b3e0616c2)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 风湿免疫小助手

EMR

2020-05-29

(审核中...)

前往app查看评论内容

全文收起 #内镜黏膜下剥离术#(ESD)是为了提高内镜黏膜切除术(EMR)切除大于2 cm病灶的能力，但与#EMR#相比需要额外的技术技巧、延长手术时间、增加出血和穿孔等不良事件的发生率。迟发性出血是#ESD#术后最常见的并发症，发生率为4.1% ~ 11.8%。虽然预防性对人工溃疡的基底血管进行#凝血#(ESD后凝血)和#质子泵抑制剂#(PPI)是胃ESD术后常规使用的方法，以最大限度地减少延迟性出血的风险，但据报道，即使使用这些方法，出血率仍为3-5.5%。

Digestive Endoscopy：抽吸凝血方法降低胃内镜黏膜下剥离术后迟发性出血的风险

2023-10-23发表于上海

ms1292405679162969 (审核中...)

前往app查看评论内容

#EMR#

JCEM：基于EMR的混合诊断模型改进家族性高胆固醇血症的诊断

2022-02-01

ms1292405679162969 (审核中...)

前往app查看评论内容

#EMR#

NEJM：罗氏旗下基因泰克的类风湿药物Actemra在COVID-19 III期临床试验中未能达到其主要终点

2021-10-23

ms1292405679162969 (审核中...)

前往app查看评论内容

#EMR#

Circulation：ω-3多不饱和脂肪酸通过resolvin E1-ChemR23轴减轻主动脉瓣狭窄

2021-06-27

ms1292405679162969 (审核中...)

前往app查看评论内容

#EMR#

FDA批准罗氏的Actemra COVID-19试验

2020-07-16

ms1292405679162969 (审核中...)

前往app查看评论内容

#EMR#

J hepatology：Emricasan在治疗非酒精性脂肪性肝炎（NASH）肝硬化合并门脉高压中患者中的疗效

2020-11-01

ms1292405679162969 (审核中...)

前往app查看评论内容

#EMR#

FDA批准Actemra（tocilizumab）治疗重症COVID-19肺炎的III期临床试验

2020-03-29

ms1292405679162969 (审核中...)

前往app查看评论内容

#EMR#

中国批准将罗氏的白细胞介素-6单抗Actemra，用于控制新型冠状病毒感染患者体内的炎症风暴

2021-02-18

ms1292405679162969 (审核中...)

前往app查看评论内容

#EMR#

Circulation：ERV1/ChemR23信号可通过调节巨噬细胞氧化低密度脂蛋白的摄取和吞噬作用来预防动脉粥样硬化

2018-12-30

ms1292405679162969 (审核中...)

前往app查看评论内容

#EMR#

CHMP对RoActemra用于活动性幼年特发性关节炎（sJIA）持积极意见

2018-12-04

ms1292405679162969 (审核中...)

前往app查看评论内容

#EMR#

2017 HKGS/HKSEMR立场声明：老年糖尿病

2018-03-24

ms1292405679162969 (审核中...)

前往app查看评论内容

#EMR#

上海儿童医院通过HIMSS EMRAM （住院）七级评审专家：我愿意把孙子放在这里治疗

2018-11-20

ms1292405679162969 (审核中...)

前往app查看评论内容

#EMR#

英国NHS同意罗氏的RoActemra（IL-6抗体）治疗巨细胞动脉炎

2018-12-15

ms1292405679162969 (审核中...)

前往app查看评论内容

#EMR#

宁波市鄞州区第二医院通过HIMSS EMRAM（住院）七级评审

2017-12-24

ms1292405679162969 (审核中...)

前往app查看评论内容

#EMR#

厉害了！这两家医院同日通过HIMSS EMRAM（住院）七级评审

2017-10-21

ms1292405679162969 (审核中...)

前往app查看评论内容

#EMR#

NHS拒绝使用罗氏的Roactemra治疗巨细胞动脉炎

2017-12-29

ms1292405679162969 (审核中...)

前往app查看评论内容

#EMR#

盛京医院通过HIMSS EMRAM七级复评

2018-06-10

ms1292405679162969 (审核中...)

前往app查看评论内容

#EMR#

HIMSS EMRAM新晋医院名单更新！

2017-03-27

ms1292405679162969 (审核中...)

前往app查看评论内容

#EMR#

DDW 2016：内镜下黏膜切除术(EMR)后粘膜缺损切缘热消融可显著减少腺瘤复发

2016-10-06

ms1292405679162969 (审核中...)

前往app查看评论内容

#EMR#

罗氏Actemra/RoActemra治疗巨细胞动脉炎维持无激素缓解（TFR）

2016-06-24

科室
- - 订阅+
  - 更多科室
工具
服务